eli lilly tirzepatide direct to consumer compounded sell Zepbound directly to consumers without insurance coverage Big news! Eli Lilly just – Ro partners with Eli Lilly – Eli Lilly Introduces New Zepbound

Tirzepatide (Zepbound 15 mg) The SURMOUNT-1 trial , which studied tirzepatide for weight loss, showed that patients taking 15 mg of tirzepatide weekly lost an average of 22.5% of their body weight over 72 weeks a significantly greater reduction compared to semaglutide

As with all medications, Semaglutide GLP-1 injections come with side effects and should only be used at the recommendation of a medical professional and exactly as prescribed

Adv Drug Delivery Rev 42:225238 Lewis AL, Mcentee N, Holland J, Patel A (2022) Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery

Check that the cold packs are still cold (or at least cool) when you receive the package